EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema (EUROPT)
A Multi-Center, Prospective, Clinical Trial Designed to Study the Efficacy of One-Way Valve Implantation Based on a New Treatment Algorithm in Patients With Heterogeneous Emphysema
Sponsor: LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
Listed as NCT00730301, this PHASE4 trial focuses on Chronic Obstructive Pulmonary Disease and Emphysema and remains ongoing. Sponsored by LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
For direct contact, visit the study record on ClinicalTrials.gov .